U
unknowninc
Iron
- Joined
- Aug 6, 2026
- Posts
- 2
- Reputation
- 1
Human Growth Hormone (HGH): Situational. Works for GH deficiency or open growth plates, not adult height. IGF-1 (Mecasermin): Situational. Effective for severe IGF-1 deficiency, not a general height drug. IGF-1 LR3: Situational. Experimental with little human evidence. IGF-1 DES: Situational. Similar to LR3, not proven for height. MK-677 (Ibutamoren): Situational. Raises GH/IGF-1, may help only with open growth plates. CJC-1295: Situational. Increases GH but no proof of height gain in healthy people. Ipamorelin: Situational. Raises GH, weak evidence for height. Sermorelin: Situational. Helps GH-deficient patients, not a magic height drug. Tesamorelin: Cope. Useful for visceral fat, not height. GHRP-2: Situational. Raises GH, little proof of increasing final height. GHRP-6: Situational. Similar to GHRP-2, increases appetite, not proven for height. Hexarelin: Situational. Potent GH releaser, limited evidence. PEG-MGF: Cope. Very little human evidence. Teriparatide: Situational. Builds bone, doesn't meaningfully increase adult height. Abaloparatide: Situational. Same as teriparatide. Romosozumab: Situational. Excellent for osteoporosis, not height. Denosumab: Cope. Prevents bone loss, doesn't increase height. BMP-2: Situational. Surgical bone-growth protein, not practical for heightmaxxing. BMP-7: Situational. Similar to BMP-2. Testosterone: Situational. Normal levels support puberty, excess may close growth plates sooner. DHT gel: Cope. Doesn't increase height. MENT (Trestolone): Cope. Very anabolic, not a height drug. Enclomiphene: Situational. Raises natural testosterone, not height. Clomiphene: Situational. Similar to enclomiphene. hCG: Situational. Restores testosterone in some cases, not height.
Skin:Tretinoin: Not cope. Gold standard for acne, collagen and anti-aging. Tazarotene: Not cope. Stronger than tretinoin but more irritating. Adapalene: Not cope. Excellent for acne, milder than tretinoin. Azelaic acid: Not cope. Great for acne, redness and hyperpigmentation. Hydroquinone: Not cope. Most effective topical for hyperpigmentation, use short-term. Tranexamic acid: Not cope. Good evidence for melasma and pigmentation. Cysteamine cream: Not cope. Effective for stubborn hyperpigmentation. Kojic acid: Situational. Works for pigmentation but weaker than hydroquinone. Alpha arbutin: Situational. Mild brightening, slower results. Hexylresorcinol: Situational. Some evidence for skin brightening. GHK-Cu: Situational. Promising for skin repair and collagen, more research needed. Copper peptides: Situational. May improve skin and hair, evidence is moderate. Bimatoprost: Not cope. Excellent for eyelash growth and may help eyebrows. Latanoprost: Situational. Can grow lashes but weaker evidence than bimatoprost. Melanotan I: Situational. Increases tanning but safety concerns. Melanotan II: Situational. Strong tanning effect with more side effects. PT-141 (Bremelanotide): Not cope. Effective for increasing sexual desire, not looks. Minoxidil: Not cope. One of the best hair growth treatments. Finasteride: Not cope. Gold standard for male pattern hair loss. Dutasteride: Not cope. Even stronger than finasteride for hair loss. RU58841: Situational. Promising anti-androgen but lacks long-term human data. Pyrilutamide (KX-826): Situational. Promising but still under investigation. CosmeRNA: Situational. Early evidence, long-term effectiveness unclear. Stemoxydine: Cope. Small cosmetic benefit at best. Clascoterone: Not cope. Effective topical anti-androgen for acne, possible future hair use.
Anabs, peps, horms
BPC-157: Situational. Promising in animal studies for healing, human evidence is limited. TB-500: Situational. Mostly animal data, not well proven in humans. Epitalon: Cope. Claims of anti-aging aren't supported by strong human evidence. MOTS-c: Situational. Early research suggests metabolic benefits, still experimental. SS-31 (Elamipretide): Situational. Promising mitochondrial peptide, not proven for longevity. FOXO4-DRI: Cope. Experimental senolytic with no established human use. ARA-290: Situational. May help nerve repair in certain conditions, limited evidence. Thymosin Alpha-1: Situational. Can support immune function in specific medical settings. KPV peptide: Situational. Early evidence for anti-inflammatory effects. Oxandrolone (Anavar): Not cope. Effective anabolic steroid for muscle with relatively lower androgenicity, still carries risks. Primobolan (Methenolone): Not cope. Effective anabolic with fewer side effects than many steroids. Masteron (Drostanolone): Not cope. Effective for a harder, drier physique when lean. Trenbolone: Not cope. Extremely powerful anabolic but also one of the highest-risk steroids. Halotestin (Fluoxymesterone): Situational. Greatly increases strength and aggression but highly toxic. Superdrol (Methasterone): Not cope. Very potent muscle builder with severe liver toxicity. Nandrolone: Not cope. Effective for muscle and strength, significant hormonal side effects. Boldenone: Not cope. Effective anabolic with slower gains. Turinabol: Not cope. Good lean muscle gains, still suppressive. Winstrol (Stanozolol): Not cope. Effective for strength and muscle hardness, harsh on joints. Oxymetholone (Anadrol): Not cope. Massive strength and size gains with high side effect risk. Anastrozole: Situational. Effective estrogen blocker only when medically indicated. Letrozole: Situational. Very potent aromatase inhibitor, inappropriate use can cause problems. Exemestane: Situational. Useful for controlling estrogen in specific cases. Eplerenone: Situational. Can reduce water retention in certain medical conditions. Spironolactone: Not cope. Effective anti-androgen for acne and female hair loss, not generally suitable for healthy males.
Mainstream social media supplements:
Aqualyx: Situational. Dissolves small fat deposits when injected correctly, not for overall weight loss.Deoxycholic acid (Kybella): Not cope. Effective for reducing submental (under-chin) fat, limited to localized fat.Semaglutide: Not cope. One of the most effective weight-loss medications with strong evidence.Tirzepatide: Not cope. Even more effective than semaglutide for many people.Retatrutide: Not cope. Extremely promising for weight loss, still becoming available in many regions.Cagrilintide: Not cope. Effective appetite suppressant, especially when combined with GLP-1 drugs.Yohimbine: Situational. Can slightly increase fat loss, especially while fasted, but the effect is modest.Oxymetazoline (Upneeq): Not cope. Effectively lifts a droopy upper eyelid for several hours.
Shilajit: Situational. May modestly improve testosterone and energy, evidence is limited.Moringa: Cope. Nutritious plant but not a major looksmaxxing supplement.Chlorophyll: Cope. Little evidence for the dramatic benefits often claimed online.Spermidine: Situational. Promising longevity research, human evidence is still developing.Urolithin A: Situational. May improve mitochondrial function and muscle health, early human evidence is encouraging.NMN: Situational. Raises NAD+ levels but anti-aging benefits remain unproven.Nicotinamide Riboside (NR): Situational. Similar to NMN, promising but not proven for longevity.Astaxanthin: Not cope. Strong antioxidant with evidence for skin and eye benefits.PQQ: Situational. May support mitochondrial health, evidence is moderate.Berberine: Not cope. Good evidence for improving blood sugar and metabolic health.TUDCA: Not cope. Good evidence for certain liver and bile-related conditions.NAC (N-Acetylcysteine): Not cope. Well-supported antioxidant with several medical uses.Colostrum: Situational. May benefit gut health and immunity, effects are modest.Fulvic acid: Cope. Very limited human evidence.MSM (Methylsulfonylmethane): Situational. May reduce joint pain and improve skin quality.Silica: Situational. May support hair, skin and nails if intake is low.Chlorella: Situational. Nutritious algae with modest health benefits.Spirulina: Not cope. Good evidence as a nutrient-rich supplement with some metabolic benefits.Hyaluronic acid: Not cope. Good evidence for skin hydration and joint support.Collagen peptides: Not cope. Good evidence for improving skin elasticity and supporting joints.DMAE: Cope. Weak evidence for skin tightening or cognitive benefits.Coenzyme Q10 (CoQ10): Not cope. Good evidence for heart health and reducing statin-related muscle symptoms.Resveratrol: Cope. Animal data are promising, but human anti-aging evidence is weak.Fisetin: Situational. Promising senolytic, human evidence is still limited.Quercetin: Situational. May have anti-inflammatory effects, longevity claims are unproven.Apigenin: Situational. Early evidence for calming and potential longevity effects.Sulforaphane: Not cope. Strong evidence for activating antioxidant pathways and supporting overall health.Alpha-lipoic acid: Not cope. Effective antioxidant with evidence for diabetic neuropathy.Glutathione: Situational. Important antioxidant, but oral supplementation has inconsistent benefits.
Skin:Tretinoin: Not cope. Gold standard for acne, collagen and anti-aging. Tazarotene: Not cope. Stronger than tretinoin but more irritating. Adapalene: Not cope. Excellent for acne, milder than tretinoin. Azelaic acid: Not cope. Great for acne, redness and hyperpigmentation. Hydroquinone: Not cope. Most effective topical for hyperpigmentation, use short-term. Tranexamic acid: Not cope. Good evidence for melasma and pigmentation. Cysteamine cream: Not cope. Effective for stubborn hyperpigmentation. Kojic acid: Situational. Works for pigmentation but weaker than hydroquinone. Alpha arbutin: Situational. Mild brightening, slower results. Hexylresorcinol: Situational. Some evidence for skin brightening. GHK-Cu: Situational. Promising for skin repair and collagen, more research needed. Copper peptides: Situational. May improve skin and hair, evidence is moderate. Bimatoprost: Not cope. Excellent for eyelash growth and may help eyebrows. Latanoprost: Situational. Can grow lashes but weaker evidence than bimatoprost. Melanotan I: Situational. Increases tanning but safety concerns. Melanotan II: Situational. Strong tanning effect with more side effects. PT-141 (Bremelanotide): Not cope. Effective for increasing sexual desire, not looks. Minoxidil: Not cope. One of the best hair growth treatments. Finasteride: Not cope. Gold standard for male pattern hair loss. Dutasteride: Not cope. Even stronger than finasteride for hair loss. RU58841: Situational. Promising anti-androgen but lacks long-term human data. Pyrilutamide (KX-826): Situational. Promising but still under investigation. CosmeRNA: Situational. Early evidence, long-term effectiveness unclear. Stemoxydine: Cope. Small cosmetic benefit at best. Clascoterone: Not cope. Effective topical anti-androgen for acne, possible future hair use.
Anabs, peps, horms
BPC-157: Situational. Promising in animal studies for healing, human evidence is limited. TB-500: Situational. Mostly animal data, not well proven in humans. Epitalon: Cope. Claims of anti-aging aren't supported by strong human evidence. MOTS-c: Situational. Early research suggests metabolic benefits, still experimental. SS-31 (Elamipretide): Situational. Promising mitochondrial peptide, not proven for longevity. FOXO4-DRI: Cope. Experimental senolytic with no established human use. ARA-290: Situational. May help nerve repair in certain conditions, limited evidence. Thymosin Alpha-1: Situational. Can support immune function in specific medical settings. KPV peptide: Situational. Early evidence for anti-inflammatory effects. Oxandrolone (Anavar): Not cope. Effective anabolic steroid for muscle with relatively lower androgenicity, still carries risks. Primobolan (Methenolone): Not cope. Effective anabolic with fewer side effects than many steroids. Masteron (Drostanolone): Not cope. Effective for a harder, drier physique when lean. Trenbolone: Not cope. Extremely powerful anabolic but also one of the highest-risk steroids. Halotestin (Fluoxymesterone): Situational. Greatly increases strength and aggression but highly toxic. Superdrol (Methasterone): Not cope. Very potent muscle builder with severe liver toxicity. Nandrolone: Not cope. Effective for muscle and strength, significant hormonal side effects. Boldenone: Not cope. Effective anabolic with slower gains. Turinabol: Not cope. Good lean muscle gains, still suppressive. Winstrol (Stanozolol): Not cope. Effective for strength and muscle hardness, harsh on joints. Oxymetholone (Anadrol): Not cope. Massive strength and size gains with high side effect risk. Anastrozole: Situational. Effective estrogen blocker only when medically indicated. Letrozole: Situational. Very potent aromatase inhibitor, inappropriate use can cause problems. Exemestane: Situational. Useful for controlling estrogen in specific cases. Eplerenone: Situational. Can reduce water retention in certain medical conditions. Spironolactone: Not cope. Effective anti-androgen for acne and female hair loss, not generally suitable for healthy males.
Mainstream social media supplements:
Aqualyx: Situational. Dissolves small fat deposits when injected correctly, not for overall weight loss.Deoxycholic acid (Kybella): Not cope. Effective for reducing submental (under-chin) fat, limited to localized fat.Semaglutide: Not cope. One of the most effective weight-loss medications with strong evidence.Tirzepatide: Not cope. Even more effective than semaglutide for many people.Retatrutide: Not cope. Extremely promising for weight loss, still becoming available in many regions.Cagrilintide: Not cope. Effective appetite suppressant, especially when combined with GLP-1 drugs.Yohimbine: Situational. Can slightly increase fat loss, especially while fasted, but the effect is modest.Oxymetazoline (Upneeq): Not cope. Effectively lifts a droopy upper eyelid for several hours.
Shilajit: Situational. May modestly improve testosterone and energy, evidence is limited.Moringa: Cope. Nutritious plant but not a major looksmaxxing supplement.Chlorophyll: Cope. Little evidence for the dramatic benefits often claimed online.Spermidine: Situational. Promising longevity research, human evidence is still developing.Urolithin A: Situational. May improve mitochondrial function and muscle health, early human evidence is encouraging.NMN: Situational. Raises NAD+ levels but anti-aging benefits remain unproven.Nicotinamide Riboside (NR): Situational. Similar to NMN, promising but not proven for longevity.Astaxanthin: Not cope. Strong antioxidant with evidence for skin and eye benefits.PQQ: Situational. May support mitochondrial health, evidence is moderate.Berberine: Not cope. Good evidence for improving blood sugar and metabolic health.TUDCA: Not cope. Good evidence for certain liver and bile-related conditions.NAC (N-Acetylcysteine): Not cope. Well-supported antioxidant with several medical uses.Colostrum: Situational. May benefit gut health and immunity, effects are modest.Fulvic acid: Cope. Very limited human evidence.MSM (Methylsulfonylmethane): Situational. May reduce joint pain and improve skin quality.Silica: Situational. May support hair, skin and nails if intake is low.Chlorella: Situational. Nutritious algae with modest health benefits.Spirulina: Not cope. Good evidence as a nutrient-rich supplement with some metabolic benefits.Hyaluronic acid: Not cope. Good evidence for skin hydration and joint support.Collagen peptides: Not cope. Good evidence for improving skin elasticity and supporting joints.DMAE: Cope. Weak evidence for skin tightening or cognitive benefits.Coenzyme Q10 (CoQ10): Not cope. Good evidence for heart health and reducing statin-related muscle symptoms.Resveratrol: Cope. Animal data are promising, but human anti-aging evidence is weak.Fisetin: Situational. Promising senolytic, human evidence is still limited.Quercetin: Situational. May have anti-inflammatory effects, longevity claims are unproven.Apigenin: Situational. Early evidence for calming and potential longevity effects.Sulforaphane: Not cope. Strong evidence for activating antioxidant pathways and supporting overall health.Alpha-lipoic acid: Not cope. Effective antioxidant with evidence for diabetic neuropathy.Glutathione: Situational. Important antioxidant, but oral supplementation has inconsistent benefits.
